Ryan T. Bishop

661 total citations
25 papers, 417 citations indexed

About

Ryan T. Bishop is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ryan T. Bishop has authored 25 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Ryan T. Bishop's work include Bone Metabolism and Diseases (10 papers), Bone health and treatments (9 papers) and NF-κB Signaling Pathways (8 papers). Ryan T. Bishop is often cited by papers focused on Bone Metabolism and Diseases (10 papers), Bone health and treatments (9 papers) and NF-κB Signaling Pathways (8 papers). Ryan T. Bishop collaborates with scholars based in United Kingdom, United States and Italy. Ryan T. Bishop's co-authors include Silvia Marino, Aymen I. Idris, Mattia Capulli, Florence I. Raynaud, Sharon Gowan, Kathryn R. Taylor, Louise D. Johnson, Khin Thway, Janet Shipley and Joanna Selfe and has published in prestigious journals such as Nature Communications, Blood and Cancer Research.

In The Last Decade

Ryan T. Bishop

22 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryan T. Bishop United Kingdom 11 214 146 88 75 58 25 417
Bryan S. Yung United States 9 249 1.2× 131 0.9× 65 0.7× 92 1.2× 38 0.7× 16 424
Ujjal K. Singha United States 17 524 2.4× 101 0.7× 40 0.5× 41 0.5× 39 0.7× 36 739
Rachel Seidman Israel 8 197 0.9× 199 1.4× 30 0.3× 133 1.8× 32 0.6× 8 445
Alain J. Kemp United Kingdom 8 279 1.3× 46 0.3× 42 0.5× 62 0.8× 32 0.6× 9 743
Molly L. Bristol United States 18 394 1.8× 288 2.0× 159 1.8× 120 1.6× 25 0.4× 32 908
Yuanfa Feng China 14 228 1.1× 56 0.4× 170 1.9× 118 1.6× 89 1.5× 43 490
Meng Hong China 11 285 1.3× 188 1.3× 214 2.4× 186 2.5× 62 1.1× 28 609
Kristina Orešić United States 7 294 1.4× 53 0.4× 65 0.7× 92 1.2× 19 0.3× 7 516
Hugo Tharinger France 8 311 1.5× 122 0.8× 142 1.6× 105 1.4× 20 0.3× 8 592

Countries citing papers authored by Ryan T. Bishop

Since Specialization
Citations

This map shows the geographic impact of Ryan T. Bishop's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan T. Bishop with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan T. Bishop more than expected).

Fields of papers citing papers by Ryan T. Bishop

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryan T. Bishop. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan T. Bishop. The network helps show where Ryan T. Bishop may publish in the future.

Co-authorship network of co-authors of Ryan T. Bishop

This figure shows the co-authorship network connecting the top 25 collaborators of Ryan T. Bishop. A scholar is included among the top collaborators of Ryan T. Bishop based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryan T. Bishop. Ryan T. Bishop is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Frieling, Jeremy S., et al.. (2025). PRDM16 Regulates Prostate Cancer Cell Dormancy and Prevents Bone Metastatic Outgrowth. Cancer Research. 86(3). 604–621.
2.
McGuire, Jeremy, et al.. (2024). Histone deacetylase upregulation of neuropilin-1 in osteosarcoma is essential for pulmonary metastasis. Cancer Letters. 606. 217302–217302. 8 indexed citations
3.
Bishop, Ryan T., Tao Li, Praneeth Sudalagunta, et al.. (2024). Acid ceramidase controls proteasome inhibitor resistance and is a novel therapeutic target for the treatment of relapsed / refractory multiple myeloma. Haematologica. 110(6). 1351–1367.
4.
Marino, Silvia, Daniela N. Petrusca, Ryan T. Bishop, et al.. (2023). Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myeloma. Haematologica. 109(5). 1501–1513. 2 indexed citations
5.
Frieling, Jeremy S., Leticia Tordesillas, María C. Ramello, et al.. (2023). γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer. Science Advances. 9(18). eadf0108–eadf0108. 44 indexed citations
6.
McGuire, Jeremy, et al.. (2023). Abstract 276: Delineating the role of vesicular glutamate transporter SLC17A7 in osteosarcoma. Cancer Research. 83(7_Supplement). 276–276. 2 indexed citations
7.
Petrusca, Daniela N., Patrick L. Mulcrone, Ryan T. Bishop, et al.. (2022). GFI1-Dependent Repression of SGPP1 Increases Multiple Myeloma Cell Survival. Cancers. 14(3). 772–772. 10 indexed citations
8.
Marino, Silvia, Nicole Hannemann, Ryan T. Bishop, et al.. (2021). Anti-inflammatory, but not osteoprotective, effect of the TRAF6/CD40 inhibitor 6877002 in rodent models of local and systemic osteolysis. Biochemical Pharmacology. 195. 114869–114869. 4 indexed citations
9.
Bishop, Ryan T., Silvia Marino, Boya Li, et al.. (2020). Combined administration of a small-molecule inhibitor of TRAF6 and Docetaxel reduces breast cancer skeletal metastasis and osteolysis. Cancer Letters. 488. 27–39. 23 indexed citations
10.
Marino, Silvia, et al.. (2019). Pharmacological Inhibition of NFκB Reduces Prostate Cancer Related Osteoclastogenesis In Vitro and Osteolysis Ex Vivo. Calcified Tissue International. 105(2). 193–204. 19 indexed citations
11.
Bishop, Ryan T., Silvia Marino, Diane V. Lefley, et al.. (2019). Pharmacological inhibition of the IKKε/TBK-1 axis potentiates the anti-tumour and anti-metastatic effects of Docetaxel in mouse models of breast cancer. Cancer Letters. 450. 76–87. 19 indexed citations
12.
Marino, Silvia, et al.. (2019). 2D and 3D In Vitro Co-Culture for Cancer and Bone Cell Interaction Studies. Methods in molecular biology. 1914. 71–98. 24 indexed citations
13.
Marino, Silvia, Ryan T. Bishop, Marco Ponzetti, et al.. (2019). Paradoxical effects of JZL184, an inhibitor of monoacylglycerol lipase, on bone remodelling in healthy and cancer-bearing mice. EBioMedicine. 44. 452–466. 37 indexed citations
14.
Marino, Silvia, Ryan T. Bishop, Asim Khogeer, et al.. (2018). TRAF2 in osteotropic breast cancer cells enhances skeletal tumour growth and promotes osteolysis. Scientific Reports. 8(1). 39–39. 28 indexed citations
15.
Marino, Silvia, Ryan T. Bishop, Patrick Mollat, & Aymen I. Idris. (2018). Pharmacological Inhibition of the Skeletal IKKβ Reduces Breast Cancer-Induced Osteolysis. Calcified Tissue International. 103(2). 206–216. 5 indexed citations
16.
Marino, Silvia, et al.. (2018). Bidirectional regulation of bone formation by exogenous and osteosarcoma-derived Sema3A. Scientific Reports. 8(1). 6877–6877. 6 indexed citations
17.
Marino, Silvia, Ryan T. Bishop, Mattia Capulli, et al.. (2018). Regulation of breast cancer induced bone disease by cancer-specific IKKβ. Oncotarget. 9(22). 16134–16148. 5 indexed citations
18.
Marino, Silvia, Ryan T. Bishop, John G. Logan, Patrick Mollat, & Aymen I. Idris. (2017). Pharmacological evidence for the bone-autonomous contribution of the NFκB/β-catenin axis to breast cancer related osteolysis. Cancer Letters. 410. 180–190. 12 indexed citations
19.
Renshaw, Jane, Kathryn R. Taylor, Ryan T. Bishop, et al.. (2013). Dual Blockade of the PI3K/AKT/mTOR (AZD8055) and RAS/MEK/ERK (AZD6244) Pathways Synergistically Inhibits Rhabdomyosarcoma Cell Growth In Vitro and In Vivo. Clinical Cancer Research. 19(21). 5940–5951. 110 indexed citations
20.
Bowman, Alan S., Stephen C. Barker, Sarah Randolph, et al.. (2008). Ticks. Cambridge University Press eBooks. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bryan S. Yung Breakdown of academic impact, for papers by Ujjal K. Singha Breakdown of academic impact, for papers by Rachel Seidman Breakdown of academic impact, for papers by Alain J. Kemp Breakdown of academic impact, for papers by Molly L. Bristol Breakdown of academic impact, for papers by Yuanfa Feng Breakdown of academic impact, for papers by Meng Hong Breakdown of academic impact, for papers by Kristina Orešić Breakdown of academic impact, for papers by Hugo Tharinger
Rankless by CCL
2026